DOI:
10.1055/s-00000064
psychoneuro
LinksClose Window
References
Danysz W. et al.
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
Int J Geriatr Psychiatry 2003; 18 (Suppl 1): S23-S32
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.